Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Off-Label Cancer Coverage Proposal Questioned By ASCO

Executive Summary

CMS' proposal to cover clinical trials evaluating four colorectal cancer drugs in off-label uses is not a wise use of taxpayer dollars, the American Society of Clinical Oncology suggests in comments on the draft policy
Advertisement

Related Content

Colorectal Cancer Policy Will Not Limit Current Off-Label Coverage, CMS Says
Colorectal Cancer Policy Will Not Limit Current Off-Label Coverage, CMS Says
CMS Developing Guidance On Coverage Decisions For Clinical Trials
CMS Developing Guidance On Coverage Decisions For Clinical Trials
PhRMA Proposes New Compendia To Guide Off-Label Rx Coverage
PhRMA Proposes New Compendia To Guide Off-Label Rx Coverage
PhRMA Proposes New Compendia To Guide Off-Label Rx Coverage
NCI Will Help CMS Make “Tough Decisions” On Cancer Drug Coverage
NCI Will Help CMS Make “Tough Decisions” On Cancer Drug Coverage

Topics

Advertisement
UsernamePublicRestriction

Register

PS045213

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel